PD

Bio & Pharma Lunit receives $1 mn in tech fees from Guardant Health of US

The US operations of South Korea's artificial intelligence (AI) medical company Lunit have received a major boost after the company got the green li...

ASK 2022 POBA targets upper-middle market in North America for PD investment

Public Officials Benefit Association (POBA) of South Korea will keep its conservative stance in both private equity and private debt investment, whi...

Korean Investors Direct lending remains the top PD strategy for Korean LPs

Around 70% of South Korean key asset owners will expand their exposure to global private debt, expecting steady streams of cash flow, according to a r...

Canyon Partners [Interview] Distressed investing to hedge PE/PD strategies: Canyon Partners

A distressed allocation can complement private equity and private debt strategies in the later stage of credit growth cycles as a record-high percenta...

.s-chart { font-family: 'Noto Sans KR', sans-serif; margin-top: 30px; } .s-chart-txt-div { /*margin...